CBAK Energy Technology Inc (CBAT): The kaboom is pouring red out of the sho...

trendzone · 2021-11-08T19:20:56.9500000Z

The kaboom is pouring red out of the shorts every opening spot's

Play Episode

7min

Proactive - Interviews for investors

Clinical study SKNJCT-003 shows positive trends as company advances skin cancer research in UAE

Medicus Pharma CEO Dr. Raza Bokhari joined Steve Darling from Proactive to share updates on the ongoing SKNJCT-003 clinical study, which is being conducted at nine sites across the United States and aims to randomize 60 patients. An interim analysis conducted after enrolling more than half of the targeted participants has shown encouraging results. The study reports a clinical clearance rate exceeding 60%, with the investigational therapy demonstrating strong tolerability across both tested dosage levels. Notably, no dose-limiting toxicities (DLTs) or serious adverse events (SAEs) have been observed, and there have been no systemic effects or clinically significant abnormalities in laboratory results, ECGs, vital signs, or physical exams. These promising findings will be submitted to the U.S. Food and Drug Administration (FDA) as part of a Type C meeting request in Q2 2025. In parallel, the company is advancing its clinical initiatives for non-invasive basal cell carcinoma treatment with a newly proposed study. This randomized, double-blind, placebo-controlled, multi-center trial has been submitted for approval to the UAE Department of Health. The study aims to enroll up to 36 patients at prominent medical institutions, including Cleveland Clinic Abu Dhabi, Sheikh Shakbout Medical City, Burjeel Medical City, and the American Hospital of Dubai. Participants will be assigned in a 1:1:1 ratio to receive either a placebo or one of two dosage levels of the experimental treatment. This expansion into the UAE represents a significant step forward in the company’s mission to develop innovative, non-invasive therapies for skin cancer, broadening its global clinical footprint and reinforcing its commitment to advancing patient care. #proactiveinvestors #nasdaq #mdcx #tsxv #mdcx #pharma #Biotech #CancerTreatment #ClinicalTrials #FDAApproval #SkinCancer #HealthcareInnovation #Investing #MedicalResearch

Proactive - Interviews for investors

Europa Oil & Gas CEO on Cloughton planning application and community engagement

Europa Oil & Gas (Holdings) Plc (AIM:EOG) CEO Will Holland talked with Proactive's Stephen Gunnion about the company's submission of a planning application for the Cloughton appraisal well in Yorkshire. The application seeks approval to drill and test a gas field originally discovered in 1986. Holland explained that advancements in technology and improved gas prices now make it viable to extract gas at commercial rates. The appraisal well will determine the feasibility of full-field development. He also discussed the launch of a dedicated community engagement website, designed to provide local stakeholders with transparent information, including independent environmental and regulatory reports. Holland emphasised that the project follows strict UK regulations and aims to minimise environmental impact. Addressing concerns, he clarified that fracking is not involved, citing confirmation from Energy Minister Michael Shanks. He also noted that increased heavy goods vehicle (HGV) traffic would be minimal, at around 1% during operations. Holland stressed the project's potential benefits, including job creation and reducing the UK's reliance on imported liquefied natural gas (LNG). “If you're concerned about the environment, you should be supporting domestic gas production. And that's exactly what this is,” he stated. For more interviews with industry leaders, visit Proactive’s YouTube channel. Don't forget to like this video, subscribe, and turn on notifications for updates! #EuropaOilAndGas #EnergySecurity #NaturalGas #UKGas #CloughtonWell #EnergyTransition #Investing #OilAndGas #SustainableEnergy #LNG

Proactive - Interviews for investors

GoviEx Uranium CEO on Muntanga feasibility study milestone and market dynamics

GoviEx Uranium CEO Daniel Major talked with Proactive's Stephen Gunnion about the company’s latest milestone—the completion and filing of the feasibility study for its Muntanga Uranium Project in Zambia. Major explained that the study underscores the project's simplicity, highlighting its open-pit heap leaching operation, low technical risk, and strong economics. GoviEx is targeting production by 2028, with financial preparations already in progress. The company has appointed Endeavor Financial to lead the debt financing process and has begun outreach to potential lenders. Meanwhile, environmental approvals are expected by year-end, paving the way for construction. Discussing uranium market dynamics, Major pointed to a growing supply deficit and increasing demand from utilities. Despite market uncertainties, term contracts remain strong at around $80 per pound. He also noted shifting supply chains, with African uranium playing a more prominent role due to restrictions on Russian and Kazakh supply. "The market needs these projects," Major stated. "GoviEx with Muntanga is one of those projects that can come in and support and fill that gap." Watch the full interview for more insights. Don’t forget to like the video, subscribe to our channel, and turn on notifications for future updates. #GoviExUranium #UraniumMining #MuntangaProject #ZambiaMining #NuclearEnergy #UraniumMarket #MiningStocks #EnergyTransition #UraniumSupply #Investing

Proactive - Interviews for investors

Eclipse Metals secures uranium partnership

Eclipse Metals Ltd (ASX:EPM) executive chairman Carl Popal talked with Proactive about the company’s earn-in agreement with Boss Energy Ltd to advance exploration at the Liverpool Uranium Project in the Northern Territory’s Alligator Rivers Uranium Field. Popal described the deal as a “game changer” that brings funding, technical expertise, and an experienced uranium producer into the project. The agreement allows Boss Energy to earn up to 80% ownership in stages by funding exploration work, with an initial commitment this year followed by further investment. Discussing the potential of the Devil’s Elbow prospect, Popal highlighted its geological similarities to the high-grade Jabiluka deposit. He emphasisd that the project has strong uranium, palladium, and gold mineralisation, with deep drilling planned to explore its full potential. Beyond uranium, Eclipse Metals is advancing its Greenland rare earths projects, with key metallurgical results expected soon. The company is optimistic that its assets, including a large carbonatite deposit, could be significant in the rare earths sector. Watch the full interview to learn more about Eclipse Metals' uranium and critical minerals strategy. Don’t forget to like the video, subscribe to Proactive’s YouTube channel, and turn on notifications for future updates. #EclipseMetals #ASX #ProactiveInvestors #BossEnergy #Uranium #Mining #Investing #RareEarths #Exploration #UraniumStocks #Greenland #CriticalMinerals #Jabiluka #DevilsElbow #StockMarket #Energy

Followers	55
Posts	4941
Boards Moderated	0
Alias Born	02/11/2020

Volume:	110,032
Day Range:	0.832 - 0.869999
Bid:	0.835
Ask:	0.87
Last Trade Time:	7:52:05 PM EDT
Total Trades:	470

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

CBAT Detailed Quote

Recent CBAT News

More CBAT News

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Recent CBAT News

Go Ad-Free